Astraformedic offers advanced solutions for molecular monitoring in transplant patients, with the objective of early assessment of organ function and detection of potential signs of rejection or dysfunction. The methodologies employed are based on high-sensitivity technologies, capable of identifying even minimal molecular variations, often indicative of subclinical criticalities.

The use of these analyses enables timely intervention, modulating immunosuppressive therapies in a targeted manner and contributing to organ preservation over time. The protocols are optimized for use on non-invasive biological samples, with streamlined workflows compatible with major laboratory technologies.

The reagents used guarantee stability and reproducibility, ensuring reliable results even in highly complex clinical contexts. The integration of molecular data with the overall clinical picture represents strategic support for transplant patient follow-up, promoting increasingly personalized management.

To complete post-transplant monitoring, Astraformedic offers solutions for chimerism analysis, useful for evaluating cellular engraftment in allogeneic hematopoietic stem cell transplants. The investigation allows for distinguishing donor and recipient components and monitoring their evolution over time.

Peripheral blood represents the reference sample for genotyping and follow-up, to be performed at regular intervals to detect early signs of rejection or instability. The proposed approach integrates into post-transplant surveillance protocols, contributing to more targeted clinical management.